Matches in Nanopublications for { ?s ?p "[Multivariate analysis determined that HER2 overexpression was associated with an increasing risk of developing metastases (OR: 4.3; 95%CI: 1.2-15.9; p: 0.03) while PTEN overexpression was associated with lower risk (OR: 0.1; 95%CI: 0.1, 1.0; p: 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[Multivariate analysis determined that HER2 overexpression was associated with an increasing risk of developing metastases (OR: 4.3; 95%CI: 1.2-15.9; p: 0.03) while PTEN overexpression was associated with lower risk (OR: 0.1; 95%CI: 0.1, 1.0; p: 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Multivariate analysis determined that HER2 overexpression was associated with an increasing risk of developing metastases (OR: 4.3; 95%CI: 1.2-15.9; p: 0.03) while PTEN overexpression was associated with lower risk (OR: 0.1; 95%CI: 0.1, 1.0; p: 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP654120.RAoVZnkHbX2C_R1IL9J22H32cxohNN86FMWvjkmS46v1U130_assertion description "[Multivariate analysis determined that HER2 overexpression was associated with an increasing risk of developing metastases (OR: 4.3; 95%CI: 1.2-15.9; p: 0.03) while PTEN overexpression was associated with lower risk (OR: 0.1; 95%CI: 0.1, 1.0; p: 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654120.RAoVZnkHbX2C_R1IL9J22H32cxohNN86FMWvjkmS46v1U130_provenance.
- NP655189.RAgA0LnvIjsub0nBNY6sILl2F5HCzYflxV4FIQB8s-YRk130_assertion description "[Multivariate analysis determined that HER2 overexpression was associated with an increasing risk of developing metastases (OR: 4.3; 95%CI: 1.2-15.9; p: 0.03) while PTEN overexpression was associated with lower risk (OR: 0.1; 95%CI: 0.1, 1.0; p: 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655189.RAgA0LnvIjsub0nBNY6sILl2F5HCzYflxV4FIQB8s-YRk130_provenance.
- NP379092.RA3xi7RB4SXD9BfHCIkCBbyH8QsH5AI5MgZLx4_BIfYzI130_assertion description "[Multivariate analysis determined that HER2 overexpression was associated with an increasing risk of developing metastases (OR: 4.3; 95%CI: 1.2-15.9; p: 0.03) while PTEN overexpression was associated with lower risk (OR: 0.1; 95%CI: 0.1, 1.0; p: 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379092.RA3xi7RB4SXD9BfHCIkCBbyH8QsH5AI5MgZLx4_BIfYzI130_provenance.
- NP380523.RA-UlC0d6nfuw6gCvl0XZzXeeoeIW3nOoIg_k62P9UIsg130_assertion description "[Multivariate analysis determined that HER2 overexpression was associated with an increasing risk of developing metastases (OR: 4.3; 95%CI: 1.2-15.9; p: 0.03) while PTEN overexpression was associated with lower risk (OR: 0.1; 95%CI: 0.1, 1.0; p: 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380523.RA-UlC0d6nfuw6gCvl0XZzXeeoeIW3nOoIg_k62P9UIsg130_provenance.
- NP1058128.RAJ2PSyQ-H5jGNHPwmKirk6hHxKA2XAd-cwTb0YAOlGEk130_assertion description "[Multivariate analysis determined that HER2 overexpression was associated with an increasing risk of developing metastases (OR: 4.3; 95%CI: 1.2-15.9; p: 0.03) while PTEN overexpression was associated with lower risk (OR: 0.1; 95%CI: 0.1, 1.0; p: 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1058128.RAJ2PSyQ-H5jGNHPwmKirk6hHxKA2XAd-cwTb0YAOlGEk130_provenance.
- NP1058129.RAxRctgWxx7rKwVN2ue2e-lL-RetKHCDpYhbsscWVytX0130_assertion description "[Multivariate analysis determined that HER2 overexpression was associated with an increasing risk of developing metastases (OR: 4.3; 95%CI: 1.2-15.9; p: 0.03) while PTEN overexpression was associated with lower risk (OR: 0.1; 95%CI: 0.1, 1.0; p: 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1058129.RAxRctgWxx7rKwVN2ue2e-lL-RetKHCDpYhbsscWVytX0130_provenance.